These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9424015)

  • 1. Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity.
    Aceto MD; Harris LS; Bowman ER
    Eur J Pharmacol; 1997 Nov; 338(3):215-23. PubMed ID: 9424015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive effect of dihydroetorphine in diabetic mice.
    Kamei J; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1995 Feb; 275(1):109-13. PubMed ID: 7774657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroetorphine is a mu-receptor-selective ligand.
    Wang DX; Lu XQ; Qin BY
    J Pharm Pharmacol; 1995 Aug; 47(8):669-73. PubMed ID: 8583370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus and antinociceptive effects of dihydroetorphine in rhesus monkeys.
    Gerak LR; Gauthier CR; France CR
    Psychopharmacology (Berl); 2003 Apr; 166(4):351-9. PubMed ID: 12601499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist and antagonist properties of dihydroetorphine for mu-opioid receptors in mice.
    Kamei J; Suzuki T; Nagase H
    Neurosci Lett; 1996 Sep; 215(2):87-90. PubMed ID: 8888002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding affinity to and dependence on some opioids in Sf9 insect cells expressing human mu-opioid receptor.
    Liu ZH; He Y; Jin WQ; Chen XJ; Zhang HP; Shen QX; Chi ZQ
    Acta Pharmacol Sin; 2003 Sep; 24(9):859-63. PubMed ID: 12956932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effect of dihydroetorphine and its tolerance/dependence liability in mice.
    Tokuyama S; Takahashi M; Kaneto H
    Biol Pharm Bull; 1993 Aug; 16(8):774-7. PubMed ID: 8220323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very long-acting narcotic antagonists: the 14 beta-p-substituted cinnamoylaminomorphinones and their partial mu agonist codeinone relatives.
    Aceto MD; Bowman ER; May EL; Harris LS; Woods JH; Smith CB; Medzihradsky F; Jacobson AE
    Arzneimittelforschung; 1989 May; 39(5):570-5. PubMed ID: 2547389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroetorphine: physical dependence and stereotypy after continuous infusion in the rat.
    Aceto MD; Scates SM; Harris LS; Ji Z
    Eur J Pharmacol; 2000 Jan; 387(1):31-7. PubMed ID: 10633157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells.
    Crain SM; Shen KF
    Brain Res; 1996 Nov; 741(1-2):275-83. PubMed ID: 9001733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence.
    Shen KF; Crain SM
    Brain Res; 1994 Feb; 636(2):286-97. PubMed ID: 8012813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitussive effect of dihydroetorphine in mice.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1994 Aug; 260(2-3):257-9. PubMed ID: 7988653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.
    Xu JY; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 1992 Oct; 263(1):246-52. PubMed ID: 1328609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of mu-opioid receptors and alpha-adrenoceptors in the immunomodulatory effects of dihydroetorphine.
    Wu WR; Zheng JW; Li FY; Li Y; Zhang KR; Bai HQ
    Eur J Pharmacol; 1998 Jul; 353(1):79-85. PubMed ID: 9721043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.